AI That Actually Gets Used: A Startup's Take on Pharma Innovation

You’re about to enter a new dimension—where the boundaries of life sciences, data, and technology blur, and AI reshapes what’s possible. Welcome to The Improzone, powered by Improzo.

In this launch episode, Jane Urban sits down with Improzo’s CEO and co-founder, Inderpreet Kambo, to talk about what happens when you stop building dashboards—and start building decisions.

Drawing from his career across ZS, IQVIA, and Takeda, Inder shares why so many AI programs in pharma fall short of real-world impact, and how Improzo was designed to fix the last mile: where insights need to become action.

“Insight doesn’t equal impact. You have to meet users where they are—and build AI that fits how they actually work.”

From KOL insights that move from PDF to action in hours, to AI copilots that operate inside the existing pharma workflow, this episode kicks off the series with a clear message: execution is everything.